Atrial Fibrillation continues to be the most common heart rhythm disorders ailing the modern society. The incidence and prevalence of atrial fibrillation is on the rise worldwide, mainly due to changes in demographic and lifestyle patterns. This has led to increased consumption of the related drugs and devices which is reflected in the continuous growth of the global atrial fibrillation market as also forecasted by the industry experts. The US and Europe are the two major regions where atrial fibrillation is the most common sustained heart rhythm disorder prevailing among masses and as observed in clinical practice.

The continuous introduction and uptake of new anticoagulants in the atrial fibrillation market and the medical fraternity’s growing support to their increased usage are two major trends being observed in the global atrial fibrillation market. Modern research has produced new hybrid treatment procedures and innovative ablation catheters for the management of atrial fibrillation. Such new products and researches are a development affecting the growth of the atrial fibrillation market all across the globe. Furthermore, improved product and treatment efficacy due to continuous research and development has resulted in their increased adoption by doctors and patients alike. Another major factor driving the growth of the global atrial fibrillation market is the increasing number of elderly and diabetic patients worldwide.

The global atrial fibrillation market is highly competitive with numerous small and large companies located throughout the world. The leading players of the market include St. Jude Medical, Boston Scientific Corporation, Johnson & Johnson's Biosense Webster, C. R. Bard, Medtronic, and Atricure, among others. As the market is characterized by rapid technological advancements, competition in research involving improvement of new and existing products and processes is particularly significant.

The report provides an analysis of the global atrial fibrillation market. It also discusses major trends, growth drivers and developments in atrial fibrillation market. The report also presents the competitive structure of the industry and profiles major players in the market with a discussion of their key business strategies.

1. Overview of Atrial Fibrillation

1.1 Introduction
1.2 Types of Atrial Fibrillation
1.3 Treatment of Atrial Fibrillation

2. Atrial Fibrillation - Market Structure

2.1 Global Market

Market Value & Growth Rate
Market Segmentation
Procedure Volume Growth

2.2 The United States

2.3 Europe

3. Atrial Fibrillation - Market Dynamics

3.1 Key Trends

3.1.1 New Blood Thinners in Atrial Fibrillation Drug Market
3.1.2 Increased Use of Anticoagulants Being Supported by Medical Fraternity

3.2 Significant Developments

3.2.1 Hybrid Atrial Fibrillation Procedure
3.2.2 Improved Blood Thinner by Pfizer and Bristol-Myers
3.2.3 Innovative Ablation Catheters

3.3 Growth Drivers

3.3.1 Novel Anticoagulants to Drive the Atrial Fibrillation Market
3.3.2 Increasing Aging Population
3.3.3 Increasing Diabetic Population

4. Atrial Fibrillation - Competitive Scenario

Competitive Overview
Growth Comparison

5. Company Profiles

5.1 St. Jude Medical, Inc.

Company Overview
Key Financials
Business Strategies
Expansion of AF Business
Strategic Acquisitions & Investments

5.2 Biosense Webster, Inc.

Company Overview
Key Financials
Business Strategies
Growth through Strategic Collaborations
New Product Introductions

5.3 C. R. Bard, Inc.

Company Overview
Key Financials
Business Strategies
Continuous Technological Innovations
Growth through Selective Acquisitions

5.4 Boston Scientific Corporation
Company Overview
Key Financials
Business Strategies
Develop and Acquire Technologies
Increase Global Market Share

6. Market Outlook

List of Charts

Global Atrial Fibrillation Market Revenues, 2008-2009
Global Atrial Fibrillation Market Growth, Q108-Q308
Global Atrial Fibrillation Market Segmentation, 2009
Worldwide Atrial Fibrillation Population Estimates, 2010 & 2015E
Worldwide Atrial Fibrillation Ablation Procedure Volume, 2009-2014E
Worldwide Atrial Fibrillation Ablation Revenues, 2010-2020E
The US Atrial Fibrillation Population, 2010-2016
EU Atrial Fibrillation Population, 2010-2016
Global Atrial Fibrillation Drug Market, 2009 & 2019
Global Ageing Population, 2007-2013F
Growth in Diabetics Population, 2004-2012F
St. Jude Medical’s Revenues by Business Segments, 2010
St. Jude Medical’s Revenues and Net Income, 2006-2010
Johnson & Johnson’s Revenues, 2008-2010
C. R. Bard’s Revenues by Business Segments, 2010
C. R. Bard’s and Vascular Segment’s Revenues, 2006-2010
Boston Scientific Corporation’s Revenues by Business Segments, 2010
Boston Scientific Corporation’s Revenues, 2006-2010
The Global Atrial Fibrillation Market Forecast, 2009 & 2015
Global Xarelto (non-risked) Sales Forecast, 2011-2021

List of Tables

Current Treatment Options for Atrial Fibrillation
Number of Patients with Diagnosed AF in European Countries, November 2010
The New Blood Thinners in the AF Market, January 2011
AF Patient CHADS Risk-Scoring System
Global Atrial Fibrillation Market Annual Growth by Companies, 2008-2009